MedPath

Dietary Effects on Circulating Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Activity and Enzyme Activity in Peripheral Blood Mononuclear Cells (PBMCs) in Patients With Prediabetes or Newly Diagnosed Type 2 Diabetes

Not Applicable
Completed
Conditions
Impaired Fasting Glucose
Newly Diagnosed Type 2 Diabetes
Interventions
Dietary Supplement: Dietary intervention-whole grains and legumes
Dietary Supplement: Dietary intervention-Refined rice
Registration Number
NCT01895387
Lead Sponsor
Yonsei University
Brief Summary

We determined the effects of dietary intervention (replacement of refined rice with whole grains and legumes and a high intake of vegetables) on circulating Lp-PLA2 activity and enzyme activity in peripheral blood mononuclear cells (PBMCs) in patients with impaired fasting glucose (IFG), impaired glucose tolerance (IGT) or newly-diagnosed type 2 diabetes.

Detailed Description

Ninety-nine patients with impaired fasting glucose (IFG), impaired glucose tolerance (IGT) or newly-diagnosed type 2 diabetes were randomly assigned to either a control group (usual diet with refined rice) or the whole grain group.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Subjects who were in in impaired fasting glucose (IFG, 100≤ fasting glucose <126 mg/dL)
  • or newly diagnosed type 2 diabetes (fasting glucose ≥126 mg/dL)
Read More
Exclusion Criteria
  • current and/or past history of cardiovascular disease including angina
  • liver or kidney dysfunction
  • thyroid or pituitary disease
  • unstable weight loss/gain (≥2 kg) over the previous 12 months
  • pregnancy or lactation
  • taking medications or supplements
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Whole grains and legumesDietary intervention-whole grains and legumes-
Refined riceDietary intervention-Refined rice-
Primary Outcome Measures
NameTimeMethod
Plasma Lp-PLA2 activityChange from baseline in Lp-PLA2 at 12 weeks
Secondary Outcome Measures
NameTimeMethod
PBMC Lp-PLA2 activityChange from baseline in PBMC Lp-PLA2 at 12 weeks

Trial Locations

Locations (1)

Yonsei University

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath